|
ENMD-2076 L-(+)-Tartaric acid
|
K030964-5mg
|
99% |
1291074-87-7 |
5mg
|
¥ 616.0
|
4~8周 |
0 |
科威 |
|
ENMD-2076 L-(+)-Tartaric acid
|
K030964-25mg
|
99% |
1291074-87-7 |
25mg
|
¥ 926.0
|
4~8周 |
0 |
科威 |
|
Rivastigmine Tartrate
|
K030963-1g
|
98% |
129101-54-8 |
1g
|
¥ 445.0
|
4~8周 |
0 |
科威 |
|
Rivastigmine Tartrate
|
K030963-5g
|
98% |
129101-54-8 |
5g
|
¥ 1567.0
|
4~8周 |
0 |
科威 |
|
PF-3084014
|
K030962-5mg
|
98% |
1290543-63-3 |
5mg
|
¥ 4686.0
|
4~8周 |
0 |
科威 |
|
PF-3084014
|
K030962-50mg
|
98% |
1290543-63-3 |
50mg
|
¥ 16874.0
|
4~8周 |
0 |
科威 |
|
PF-3084014
|
K030962-25mg
|
98% |
1290543-63-3 |
25mg
|
¥ 10312.0
|
4~8周 |
0 |
科威 |
|
PF-3084014
|
K030962-10mg
|
98% |
1290543-63-3 |
10mg
|
¥ 7124.0
|
4~8周 |
0 |
科威 |
|
3-氨基-3-(2-萘基)丙酸
|
K001224-5g
|
97% |
129042-57-5 |
5g
|
¥ 873.0
|
現(xiàn)貨 |
0 |
科威 |
|
3-氨基-3-(2-萘基)丙酸
|
K001224-1g
|
97% |
129042-57-5 |
1g
|
¥ 291.0
|
現(xiàn)貨 |
0 |
科威 |
|
芘
|
K006897-5g
|
99% |
129-00-0 |
5g
|
¥ 518.0
|
現(xiàn)貨 |
0 |
科威 |
|
芘
|
K006897-25g
|
99% |
129-00-0 |
25g
|
¥ 1698.0
|
現(xiàn)貨 |
0 |
科威 |
|
芘
|
K006897-1g
|
99% |
129-00-0 |
1g
|
¥ 188.0
|
現(xiàn)貨 |
0 |
科威 |
|
芘
|
K006896-100g
|
97% |
129-00-0 |
100g
|
¥ 440.0
|
現(xiàn)貨 |
0 |
科威 |
|
芘
|
K006896-500g
|
97% |
129-00-0 |
500g
|
¥ 1121.0
|
現(xiàn)貨 |
0 |
科威 |
|
芘
|
K006896-25g
|
97% |
129-00-0 |
25g
|
¥ 145.0
|
現(xiàn)貨 |
0 |
科威 |
|
4-芐基丁氧基苯酰肼
|
K016325-1g
|
97% |
128958-65-6 |
1g
|
¥ 426.0
|
4~8周 |
0 |
科威 |
|
4-芐基丁氧基苯酰肼
|
K016325-5g
|
97% |
128958-65-6 |
5g
|
¥ 1368.0
|
4~8周 |
0 |
科威 |
|
1,4-二氨基蒽醌
|
K006022-500g
|
90% |
128-95-0 |
500g
|
¥ 1573.0
|
現(xiàn)貨 |
0 |
科威 |
|
1,4-二氨基蒽醌
|
K006022-100g
|
90% |
128-95-0 |
100g
|
¥ 525.0
|
現(xiàn)貨 |
0 |
科威 |
|
1,4-二氨基蒽醌
|
K006022-25g
|
90% |
128-95-0 |
25g
|
¥ 173.0
|
現(xiàn)貨 |
0 |
科威 |
|
1-甲胺-4-溴蒽醌
|
K030961-10mg
|
98% |
128-93-8 |
10mg
|
¥ 1117.0
|
4~8周 |
0 |
科威 |
|
BMS-927711
|
K030960-25mg
|
98% |
1289023-67-1 |
25mg
|
¥ 12374.0
|
4~8周 |
0 |
科威 |
|
BMS-927711
|
K030960-10mg
|
98% |
1289023-67-1 |
10mg
|
¥ 5774.0
|
4~8周 |
0 |
科威 |